Ilex Medical Ltd (ILX.TA)
ILA 6225.0
(1.68%)
ILA 6225.0
(1.68%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 154.33 Million ILS | 7.42% |
| 2022 | 147.75 Million ILS | 9.41% |
| 2021 | 135.05 Million ILS | 6.93% |
| 2020 | 126.3 Million ILS | 5.57% |
| 2019 | 119.63 Million ILS | 8.54% |
| 2018 | 110.21 Million ILS | 10.94% |
| 2017 | 99.35 Million ILS | 0.81% |
| 2016 | 98.55 Million ILS | -13.54% |
| 2015 | 113.98 Million ILS | 30.74% |
| 2014 | 87.18 Million ILS | -42.15% |
| 2013 | 150.72 Million ILS | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 39.34 Million ILS | -5.63% |
| 2024 Q2 | 40.4 Million ILS | 1.25% |
| 2023 Q3 | 38.83 Million ILS | 2.14% |
| 2023 Q4 | 41.69 Million ILS | 7.34% |
| 2023 FY | 158.71 Million ILS | 7.42% |
| 2023 Q1 | 40.16 Million ILS | 5.26% |
| 2023 Q2 | 38.02 Million ILS | -5.32% |
| 2022 FY | 147.75 Million ILS | 9.41% |
| 2022 Q4 | 38.15 Million ILS | 4.64% |
| 2022 Q3 | 36.46 Million ILS | -2.81% |
| 2022 Q2 | 37.51 Million ILS | 5.3% |
| 2022 Q1 | 35.62 Million ILS | 3.0% |
| 2021 Q2 | 32.59 Million ILS | 0.17% |
| 2021 Q4 | 34.59 Million ILS | -2.1% |
| 2021 Q3 | 35.33 Million ILS | 8.41% |
| 2021 Q1 | 32.53 Million ILS | -0.86% |
| 2021 FY | 135.05 Million ILS | 6.93% |
| 2020 Q3 | 32.43 Million ILS | 8.73% |
| 2020 Q1 | 31.21 Million ILS | 0.78% |
| 2020 Q2 | 29.83 Million ILS | -4.42% |
| 2020 Q4 | 32.81 Million ILS | 1.17% |
| 2020 FY | 126.3 Million ILS | 5.57% |
| 2019 Q4 | 30.96 Million ILS | 4.73% |
| 2019 FY | 119.63 Million ILS | 8.54% |
| 2019 Q2 | 28.97 Million ILS | -3.78% |
| 2019 Q1 | 30.11 Million ILS | 2.62% |
| 2019 Q3 | 29.56 Million ILS | 2.04% |
| 2018 Q3 | 26.2 Million ILS | -4.94% |
| 2018 Q1 | 27.1 Million ILS | 4.4% |
| 2018 Q2 | 27.56 Million ILS | 1.72% |
| 2018 FY | 110.21 Million ILS | 10.94% |
| 2018 Q4 | 29.34 Million ILS | 11.99% |
| 2017 Q3 | 25.07 Million ILS | 5.91% |
| 2017 Q4 | 25.95 Million ILS | 3.53% |
| 2017 FY | 99.35 Million ILS | 0.81% |
| 2017 Q1 | 24.64 Million ILS | 5.06% |
| 2017 Q2 | 23.67 Million ILS | -3.94% |
| 2016 Q2 | 25.46 Million ILS | -0.19% |
| 2016 Q3 | 24.12 Million ILS | -5.26% |
| 2016 Q1 | 25.51 Million ILS | -36.38% |
| 2016 Q4 | 23.45 Million ILS | -2.75% |
| 2016 FY | 98.55 Million ILS | -13.54% |
| 2015 Q2 | 22.06 Million ILS | 3.81% |
| 2015 Q1 | 21.25 Million ILS | -37.16% |
| 2015 FY | 113.98 Million ILS | 30.74% |
| 2015 Q4 | 40.09 Million ILS | 52.15% |
| 2015 Q3 | 26.35 Million ILS | 19.46% |
| 2014 FY | 87.18 Million ILS | -42.15% |
| 2014 Q4 | 33.82 Million ILS | 213.04% |
| 2014 Q3 | 10.8 Million ILS | -50.41% |
| 2014 Q2 | 21.78 Million ILS | -10.2% |
| 2014 Q1 | 24.26 Million ILS | -68.72% |
| 2013 Q2 | 23.04 Million ILS | 5.6% |
| 2013 Q4 | 77.55 Million ILS | 252.7% |
| 2013 FY | 150.72 Million ILS | 0.0% |
| 2013 Q3 | 21.98 Million ILS | -4.59% |
| 2013 Q1 | 21.82 Million ILS | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|